BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript
BIOLASE, Inc. beats earnings expectations. Reported EPS is $-1.76, expectations were $-2.56.
Source: insidermonkey.com
Waterlase Trials Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Waterlase Trials Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Waterlase Trials Program Today - Breaking & Trending Today